What is the interpretation of an annual incidence of 15 breast cancer cases per 1000 people in a female population?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Breast Cancer Incidence

The correct interpretation is D) 15 people out of 1000 population will develop breast cancer in one year—this represents an incidence rate of 15 per 1000 person-years (or 1500 per 100,000 per year). 1

Understanding Incidence vs. Prevalence

  • Incidence measures new cases developing over a specific time period in a defined population at risk, which is exactly what this study describes—15 new breast cancer cases among 1000 people followed for one year 1

  • This is not prevalence (option A suggesting "15% have breast cancer"), which would measure existing cases at a single point in time 2

  • The rate is expressed as 15 per 1000 person-years, which can also be written as 1500 per 100,000 women per year 1

Clinical Context: This is an Elevated Detection Rate

This observed rate of 15 per 1000 is substantially higher than average population incidence and likely represents a high-risk screening population or prevalent screen:

  • Average population incidence in Europe is approximately 1.1 per 1000 (109.9 per 100,000), which is more than 10-fold lower than the observed rate 1

  • The U.S. population incidence is approximately 1.24 per 1000 (124.2 per 100,000) 1

  • High-risk screening populations (such as BRCA mutation carriers or women with dense breasts) show cancer detection rates of 8-29 per 1000, which aligns with this observed rate of 15 per 1000 1

Why This Rate is Elevated

Several factors explain detection rates this high:

  • Prevalent screen effect: First-round screening detects both new cancers and pre-existing undiagnosed cancers, with subsequent screening rounds typically showing much lower rates (3.7-5.3 per 1000) 1

  • High-sensitivity screening modalities: Abbreviated MRI screening demonstrates detection rates of 15 per 1000 in women with dense breasts and elevated risk profiles 1

  • Enriched risk factors: The population likely includes women with dense breasts (relative risk 1.2-2.1), family history (19% of similar populations), or other risk factors 1

Common Pitfalls to Avoid

  • Do not confuse incidence with prevalence: The 15 cases are new diagnoses during the observation period, not the total number of women living with breast cancer 1

  • Do not assume this rate applies to average-risk populations: This is 10-15 times higher than typical population incidence and represents either high-risk women or a prevalent screening round 1

  • Do not extrapolate linearly: The rate of 15 per 1000 per year does not mean 150 per 1000 over 10 years, as the denominator changes as cases are diagnosed 1

  • Age matters significantly: Less than 5% of breast cancers occur before age 35, and approximately 25% occur before age 50, so age distribution of the cohort substantially affects observed rates 1, 3

References

Guideline

Breast Cancer Detection Rates in High-Risk Populations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Breast Cancer Risk Factors and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.